Bladder-preserving therapy using a real-time tumor-tracking radiotherapy system for muscle-invasive bladder cancer.

被引：0
|
作者：
Miyata, Haruka
Osawa, Takahiro
Frumido, Jun
Kikuchi, Hiroshi
Matsumoto, Ryuji
Abe, Takashige
Maruyama, Satoru
Nishioka, Kentaro
Shimizu, Shinichi
Hashimoto, Takayuki
Shirato, Hiroki
Shinohara, Nobuo
机构：
[1] Hokkaido Univ, Dept Renal & Genitourinary Surg, Sapporo, Hokkaido, Japan
[2] Hokkaido Univ, Dept Radiat Oncol, Sapporo, Hokkaido, Japan
[3] Hokkaido Univ, Dept Radiat Med, Sapporo, Hokkaido, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.364
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
364
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The updated outcomes of bladder-preserving trimodal therapy using a real-time tumor-tracking radiotherapy system for patients with muscle-invasive bladder cancer
    Miyata, Haruka
    Osawa, Takahiro
    Abe, Takashige
    Kikuchi, Hiroshi
    Matsumoto, Ryuji
    Maruyama, Satoru
    Nishioka, Kentaro
    Shimizu, Shinichi
    Hashimoto, Takayuki
    Shirato, Hiroki
    Shinohara, Nobuo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (05) : 609 - 616
  • [2] Selective bladder-preserving therapy for muscle-invasive cancer
    Heney, Niall M.
    Kaufman, Donald S.
    Shipley, William U.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (04) : 193 - 194
  • [3] Selective bladder-preserving therapy for muscle-invasive cancer
    Niall M. Heney
    Donald S. Kaufman
    William U. Shipley
    Nature Reviews Clinical Oncology, 2009, 6 : 193 - 194
  • [4] Long-term Outcomes of Tri-modality Therapy using a real-time tumor-tracking radiotherapy system for Patients with Muscle-invasive Bladder Cancer
    Miyata, Haruka
    Osawa, Takahiro
    Matsumoto, Ryuji
    Abe, Takashige
    Maruyama, Satoru
    Nishioka, Kentaro
    Shimizu, Shinichi
    Hashimoto, Takayuki
    Shirato, Hiroki
    Shinohara, Nobuo
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 : 321 - 321
  • [5] Bladder-Preserving Radiation Therapy for Elderly Patients With Muscle-Invasive Bladder Cancer
    Kreofsky, C. R.
    Merrell, K. W.
    Choo, C. S.
    Mutter, R. W.
    Pisansky, T. M.
    Davis, B. J.
    Choo, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E222 - E223
  • [6] Analysis of Intravesical Recurrence After Bladder-preserving Therapy for Muscle-invasive Bladder Cancer
    Onozawa, Mizuki
    Miyanaga, Naoto
    Hinotsu, Shiro
    Miyazaki, Jun
    Oikawa, Takehiro
    Kimura, Tomokazu
    Takaoka, Ei-ichiro
    Kawai, Koji
    Shimazui, Toru
    Sakurai, Hideyuki
    Nishiyama, Hiroyuki
    Akaza, Hideyuki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (09) : 825 - 830
  • [7] Current state of the art: Bladder-preserving trimodality therapy for muscle-invasive bladder cancer
    Efstathiou, Jason A.
    CLINICAL CANCER RESEARCH, 2024, 30 (10)
  • [8] Contemporary and Emerging Approaches to Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer
    Konieczkowski, David J.
    Efstathiou, Jason A.
    Mouw, Kent W.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 35 (03) : 567 - 584
  • [9] Bladder-preserving therapy for muscle-invasive bladder cancer: Should it be recommended to appropriate patients?
    Hideyuki Akaza
    Current Urology Reports, 2008, 9 (4) : 257 - 258
  • [10] Vinorelbine in Bladder-Preserving Multimodality Treatment for Muscle-Invasive Bladder Cancer
    Arnold, C.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1150 - S1150
12345